DENTSPLY SIRONA Strong On Deal Renewals, Forex Woes Stay

 | Oct 11, 2017 09:00PM ET

On Oct 11, we issued an updated research report on New York-based DENTSPLY SIRONA Inc. (NASDAQ:XRAY) — a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.

DENTSPLY recently announced the renewal of an existing distribution agreement with Henry Schein (NASDAQ:HSIC) Canada, Inc, which will continue till Dec 31, 2020. Henry Schein's agreement with DENTSPLY was initiated in August 2005.

We feel that the deal extension is a smart move by DENTSPLY as the preexisting agreement did not include the CEREC CAD/CAM restoration system and the Schick line of imaging sensors. By including the aforementioned lines of products, the company will benefit from Henry Schein’s distribution network in Canada.

Among the recent developments, DENTSPLY announced the renewal of its partnership with Pacific Dental Services. The duo’s latest agreement extends for a period of five years which was signed in 2012.
This move is also a strategic one as Pacific Dental’s network consists of over 580 centers across 17 states. During the tenure of the present agreement, management expects the number of such offices utilizing DENTSPLY technologies to exceed 800.

DENTSPLY’s dual branding strategy, product innovation, growth opportunities in emerging markets (especially Asia-Pacific and Middle East/Africa), diversified product portfolio and recurring revenue base are key catalysts. The company expects a solid guidance for full-year 2017 projecting adjusted EPS in the range of $2.65-$2.75.

On the flip side, apart from a series of macroeconomic headwinds, currency fluctuation continues to be a major dampener. In fact, strengthening of the U.S. dollar against Euro and other emerging market currencies has dented the company’s growth trajectory. Furthermore, higher capital expenditure on product development is expected to keep margins under pressure.

Share Price & Estimate Revisions Lack Luster

DENTSPLY's estimate revision trend looks unfavorable at the moment. For the third quarter, two analysts moved south, compared to no upward revision in the last two months. Notably, the current quarter estimates dropped 1.5% to 67 cents per share over the last 60 days.

DENTSPLY’s share price movement has been unfavorable over the last three months. The company shed 11.7%, much higher than the Zacks Investment Research

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes